PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1538620
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1538620
Global Food Allergy Market Size study, by Food Source, by Diagnosis, by Treatment Type, by Distribution Channel and Regional Forecasts 2022-2032
The Global Food Allergy Market was valued at approximately USD 36.9 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.9% over the forecast period 2024-2034. Food allergy is an immune system reaction that occurs when the body mistakenly identifies a specific food protein as harmful. This erroneous immune response triggers a range of symptoms, which can vary from mild, such as hives and itching, to severe, such as anaphylaxis, a potentially life-threatening condition characterized by difficulty breathing, a drop in blood pressure, and loss of consciousness. Common allergenic foods include peanuts, tree nuts, milk, eggs, soy, wheat, fish, and shellfish. Food allergies can develop at any age and may persist throughout life or resolve over time. Managing food allergies involves strict avoidance of the offending foods, careful reading of food labels, and carrying emergency medication like epinephrine to treat accidental exposures.
The exponential growth of the Global Food Allergy Market is primarily driven by the rise in the number of patients aged 18 and below coupled with increasing cases of asthma resulting from the intake of allergenic foods. Various government and private entities are providing substantial monetary support to devise medications against food allergies. Food allergy refers to an immune system reaction to certain food substances, which can trigger symptoms such as swollen airways or digestive issues. In severe cases, food allergies can lead to life-threatening reactions like anaphylaxis. The rise in funding for allergy treatments is catalyzing advancements in research and improving access to innovative therapies. For instance, in September 2022, COUR Pharmaceuticals completed a financing round worth USD 30 million to support the expansion of its innovative immune-modifying nanoparticles technology platform.
Companies operating in the food allergy market are focused on developing injectable as well as oral drugs to combat food allergies, especially in cases of accidental exposure to allergenic foods. These companies are also exploring untapped geographies in Asia Pacific, Latin America, and the Middle East & Africa to expand their market presence.
The key regions considered in the study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. The North American region is the leading and fastest-growing region in the global food allergy market. This growth is driven by the high prevalence of food allergies, increased awareness and diagnosis, and a robust healthcare system that supports advanced allergy testing and treatment options. In the United States and Canada, rising rates of food allergies among both children and adults have led to greater demand for innovative therapies, including allergen immunotherapy and advanced diagnostic tools. Additionally, public awareness campaigns and educational programs about food allergies contribute to the growth of the market. Regulatory support for food labeling and safety standards further enhances market expansion, making North America a key player in the food allergy market.
Major market players included in this report are:
- Akorn Operating Company LLC
- Pfizer Inc.
- GSK plc
- Novartis AG
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Sanofi S.A.
- Boehringer Ingelheim
- AstraZeneca plc
- Bayer AG
- Merck & Co., Inc.
- F. Hoffmann-La Roche Ltd.
- EpiPen (owned by Mylan)
- Sierra Allergy
- Pharmaxis Ltd.
The detailed segments and sub-segment of the market are explained below:
By Food Source:
- Dairy Products
- Poultry Products
- Tree Nuts
- Peanuts
- Shellfish
- Wheat
- Others
By Diagnosis:
- Skin-prick Tests
- Blood Test
- Elimination Diet
- Others
By Treatment Type:
- Epinephrine
- Antihistamines
- Oral Immunotherapy
- Others
By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Rest of Middle East
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Years considered for the study are as follows:
- Historical year - 2022
- Base year - 2023
- Forecast period - 2024 to 2032
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2022 to 2032.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1. Global Food Allergy Market Executive Summary
- 1.1. Global Food Allergy Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Food Source
- 1.3.2. By Diagnosis
- 1.3.3. By Treatment Type
- 1.3.4. By Distribution Channel
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Food Allergy Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
Chapter 3. Global Food Allergy Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Rise in Incidence of Asthma
- 3.1.2. Increase in Incidence of Food Allergy in Children
- 3.2. Market Challenges
- 3.2.1. High Cost of Allergy Treatments
- 3.2.2. Lack of Awareness in Emerging Markets
- 3.3. Market Opportunities
- 3.3.1. Expansion into Untapped Geographies
- 3.3.2. Technological Advancements in Allergy Testing and Treatment
Chapter 4. Global Food Allergy Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
- 4.3. Top investment opportunity
- 4.4. Top winning strategies
- 4.5. Disruptive Trends
- 4.6. Industry Expert Perspective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Food Allergy Market Size & Forecasts by Food Source 2022-2032
- 5.1. Segment Dashboard
- 5.2. Global Food Allergy Market: Food Source Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Dairy Products
- 5.2.2. Poultry Products
- 5.2.3. Tree Nuts
- 5.2.4. Peanuts
- 5.2.5. Shellfish
- 5.2.6. Wheat
- 5.2.7. Others
Chapter 6. Global Food Allergy Market Size & Forecasts by Diagnosis 2022-2032
- 6.1. Segment Dashboard
- 6.2. Global Food Allergy Market: Diagnosis Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Skin-prick Tests
- 6.2.2. Blood Test
- 6.2.3. Elimination Diet
- 6.2.4. Others
Chapter 7. Global Food Allergy Market Size & Forecasts by Treatment Type 2022-2032
- 7.1. Segment Dashboard
- 7.2. Global Food Allergy Market: Treatment Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Epinephrine
- 7.2.2. Antihistamines
- 7.2.3. Oral Immunotherapy
- 7.2.4. Others
Chapter 8. Global Food Allergy Market Size & Forecasts by Distribution Channel 2022-2032
- 8.1. Segment Dashboard
- 8.2. Global Food Allergy Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Hospital Pharmacy
- 8.2.2. Retail Pharmacy
- 8.2.3. Online Pharmacy
Chapter 9. Global Food Allergy Market Size & Forecasts by Region 2022-2032
- 9.1. North America Food Allergy Market
- 9.1.1. U.S. Food Allergy Market
- 9.1.1.1. Food Source breakdown size & forecasts, 2022-2032
- 9.1.1.2. Diagnosis breakdown size & forecasts, 2022-2032
- 9.1.1.3. Treatment Type breakdown size & forecasts, 2022-2032
- 9.1.1.4. Distribution Channel breakdown size & forecasts, 2022-2032
- 9.1.2. Canada Food Allergy Market
- 9.1.1. U.S. Food Allergy Market
- 9.2. Europe Food Allergy Market
- 9.2.1. U.K. Food Allergy Market
- 9.2.2. Germany Food Allergy Market
- 9.2.3. France Food Allergy Market
- 9.2.4. Italy Food Allergy Market
- 9.2.5. Spain Food Allergy Market
- 9.2.6. Rest of Europe Food Allergy Market
- 9.3. Asia-Pacific Food Allergy Market
- 9.3.1. China Food Allergy Market
- 9.3.2. India Food Allergy Market
- 9.3.3. Japan Food Allergy Market
- 9.3.4. Australia Food Allergy Market
- 9.3.5. Rest of Asia Pacific Food Allergy Market
- 9.4. Latin America Food Allergy Market
- 9.4.1. Brazil Food Allergy Market
- 9.4.2. Mexico Food Allergy Market
- 9.4.3. Rest of Latin America Food Allergy Market
- 9.5. Middle East & Africa Food Allergy Market
- 9.5.1. Saudi Arabia Food Allergy Market
- 9.5.2. South Africa Food Allergy Market
- 9.5.3. Rest of Middle East & Africa Food Allergy Market
Chapter 10. Competitive Intelligence
- 10.1. Key Company SWOT Analysis
- 10.2. Top Market Strategies
- 10.3. Company Profiles
- 10.3.1. Akorn Operating Company LLC
- 10.3.1.1. Key Information
- 10.3.1.2. Overview
- 10.3.1.3. Financial (Subject to Data Availability)
- 10.3.1.4. Product Summary
- 10.3.1.5. Market Strategies
- 10.3.2. Pfizer Inc.
- 10.3.3. GSK plc
- 10.3.4. Novartis AG
- 10.3.5. Mylan N.V.
- 10.3.6. Teva Pharmaceutical Industries Ltd.
- 10.3.7. Sanofi S.A.
- 10.3.8. Boehringer Ingelheim
- 10.3.9. AstraZeneca plc
- 10.3.10. Bayer AG
- 10.3.11. Merck & Co., Inc.
- 10.3.12. F. Hoffmann-La Roche Ltd.
- 10.3.13. EpiPen (owned by Mylan)
- 10.3.14. Sierra Allergy
- 10.3.15. Pharmaxis Ltd
- 10.3.1. Akorn Operating Company LLC
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
